Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2022-03-08 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 7,032 | $135.21 | $950,796.72 | -9.4% | → |
| 2022-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 661 | $130.00 | $85,930.00 | -1.7% | → |
| 2022-02-24 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 2,750 | $126.26 | $347,215.00 | -4.1% | → |
| 2022-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,669 | $126.26 | $210,727.94 | -4.3% | → |
| 2021-11-29 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sale+OE | 37,565 | $156.81 | $5,890,575.48 | -7.6% | → |
| 2021-07-29 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sale+OE | 149,244 | $140.19 | $20,922,095.88 | -14.9% | → |
| 2021-07-27 | WILENSKY GAIL R | - | Sale+OE | 12,222 | $139.30 | $1,702,469.60 | -25.5% | → |
| 2021-07-27 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sale+OE | 38,601 | $140.01 | $5,404,543.91 | -6.4% | → |
| 2021-05-07 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 8,536 | $139.96 | $1,194,724.17 | -11.0% | → |
| 2021-05-05 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale+OE | 44,939 | $137.00 | $6,156,643.00 | -52.8% | → |
| 2021-03-10 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 5,574 | $120.47 | $671,499.78 | -12.2% | → |
| 2021-02-25 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 801 | $115.49 | $92,507.49 | -2.0% | → |
| 2021-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,188 | $116.95 | $138,936.60 | -1.4% | → |
| 2020-12-24 | GUINAN MARK | Executive Vice President & CFO | Sale+OE | 81,756 | $120.37 | $9,840,673.22 | -32.5% | → |
| 2020-11-24 | WILENSKY GAIL R | - | Sale+OE | 6,111 | $126.02 | $770,120.44 | -27.0% | → |
| 2020-11-23 | STANZIONE DANIEL | - | Sell | 11,223 | $126.30 | $1,417,458.52 | -10.8% | → |
| 2020-10-21 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sale+OE | 10,450 | $125.00 | $1,306,250.00 | -16.0% | → |
| 2020-10-16 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sale+OE | 291,997 | $120.00 | $35,039,640.00 | -55.1% | → |
| 2020-10-14 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale+OE | 35,591 | $119.00 | $4,235,329.00 | -47.0% | → |
| 2020-09-02 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sale+OE | 58,392 | $110.60 | $6,458,342.82 | -29.3% | → |
| 2020-06-08 | GUINAN MARK | Executive Vice President & CFO | Sale+OE | 72,596 | $117.23 | $8,510,585.04 | -22.1% | → |
| 2020-06-08 | RING TIMOTHY M | - | Sale+OE | 11,730 | $116.60 | $1,367,718.00 | -36.4% | → |
| 2020-04-27 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sale+OE | 11,717 | $112.01 | $1,312,432.89 | -4.7% | → |
| 2020-04-27 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 5,000 | $111.02 | $555,075.00 | -9.6% | → |
| 2020-03-16 | Davis J. E. | EVP, General Diagnostics | Sell | 3,513 | $87.75 | $308,251.21 | -1.7% | → |
| 2020-03-11 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 2,175 | $104.25 | $226,743.75 | -5.1% | → |
| 2020-03-11 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 2,501 | $104.25 | $260,729.25 | -3.5% | → |
| 2020-03-10 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sale+OE | 100 | $112.19 | $11,219.00 | - | → |
| 2020-03-06 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sale+OE | 171,025 | $112.21 | $19,190,202.18 | -37.4% | → |